Items where authors include "Glimelius, B."

Article

Group, F.C., Glasbey, J., Beggs, A. et al. (430 more authors) (2024) Risk of Bowel Obstruction in Patients Undergoing Neoadjuvant Chemotherapy for High-risk Colon Cancer. Annals of Surgery, 280 (2). pp. 283-293. ISSN 0003-4932

Neoptolemos, J.P., Palmer, D.H., Ghaneh, P. et al. (32 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

Berndt, S.I., Camp, N.J., Skibola, C.F. et al. (123 more authors) (2016) Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature Communications, 7. 10933. ISSN 2041-1723

Cozen, W., Timofeeva, M. N., Diepstra, A. et al. (63 more authors) (2014) A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus. Nature Communications. 3856. ISSN 2041-1723

Berndt, S.I., Skibola, C.F., Joseph, V. et al. (127 more authors) (2013) Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nature Genetics, 45 (8). pp. 868-876. ISSN 1061-4036

Proceedings Paper

Seligmann, J., Morton, D., Seymour, M. et al. (11 more authors) (2023) 552O FOxTROT: Results of embedded phase II evaluating the addition of panitumumab (pan) to neo-adjuvant FOLFOX for patients (pts) with KRAS-wt colon cancer (CC) with extended biomarker panel. In: Annals of Oncology. ESMO Congress 2023, 2023-10-20 2023-10-24, Madrid, Spain. Elsevier , S412-S412.